scholarly journals Writing the pregnant man

2015 ◽  
Vol 20 ◽  
Author(s):  
Mary Ingram-Waters
Keyword(s):  
Online Community ◽  
Medical Knowledge ◽  
Reproductive Technologies ◽  
Harry Potter ◽  
Reproductive Technology ◽  
Gender And Sexuality ◽  
Male Pregnancy

This article explores how an online community of female fans of Harry Potter creates and maintains scientific and medical knowledge of a novel reproductive technology, male pregnancy. In an effort to illuminate the mechanisms of fandom, I show how fandom participants collectively work to ensure the maintenance of standards for fan products and in doing so also selectively reinforce particular tropes about how male pregnancy is portrayed. Fans' validation of some male pregnancy variations over others results in a fascinating yet recognizable set of fictional reproductive technologies that both queer and accommodate normative gender and sexuality roles.

scholarly journals Significance of disorders of proteomic profile of follicular fluid for predicting the effectiveness of in vitro fertilisation in women with infertility

2018 ◽  
Vol 99 (3) ◽  
pp. 496-503
Author(s):  
O S Zolotykh ◽  
S V Lomteva ◽  
K Yu Sagamonova
Keyword(s):  
Assisted Reproductive Technology ◽  
Follicular Fluid ◽  
Molecular Mechanisms ◽  
Reproductive Technologies ◽  
Reproductive Technology ◽  
In Vitro Fertilisation ◽  
Proteomic Profile ◽  
Technology Programs ◽  
Group 2

Aim. To study the proteomic profile of follicular fluid in patients with infertility in assisted reproductive technology programs. Methods. The study included women with infertility included in assisted reproductive technology programs: 15 women who had in vitro fertilisation which resulted in pregnancy (group 1) and 16 women with a negative result of this program (group 2). Fractionation of the follicular fluid samples was performed using the sets of special magnetic beads. Proteomic profiling was performed by tandem MALDI-mass-spectrometry. The anti-Müllerian hormone level was measured by ELISA. Results. The study revealed differences in the detectability of follicular fluid proteins with different regulatory properties in patients of groups 1 and 2. With the negative outcome of in vitro fertilisation, expression of a number of proteins involved in the processes of folliculogenesis, ovulation, selection of the dominant follicle, as well as proteins necessary for the development of the zygote and blastula was reduced in females' follicular fluid. Increased expression in women from group 2 was registered for proteins enhancing proteolytic reactions, cell apoptosis, including oocytes, which disrupt the positive action of activin and damage structural and functional state of mitochondria. A definite relationship was found between the level of anti-Müllerian hormone and rate of detection of a number of proteins, in particular protocadherin-2α, cystatin C, betaglycan, prostatic acid phosphatase, and dermicidin. Conclusion. The revealed changes in proteomic profile of the follicular fluid obviously play an important role in the molecular mechanisms that determine the effectiveness of assisted reproductive technologies; the identified differentially expressed proteins can serve as objective markers for predicting the outcomes of in vitro fertilisation.

scholarly journals Does the Human Assisted Reproductive Technology Act 2004 need a review?

2021 ◽  
Vol 17 (1) ◽  
Author(s):  
Michael Legge ◽  
Ruth Fitzgerald
Keyword(s):  
New Zealand ◽  
Assisted Reproductive Technology ◽  
Assisted Reproductive Technologies ◽  
Reproductive Technologies ◽  
Reproductive Technology ◽  
Good Coverage

The use of assisted reproductive technologies (ART) in New Zealand is governed by the Human Assisted Reproductive Technology Act 2004 (the HART Act), which provides for all procedures currently undertaken by fertility clinics and other centres involved with ART. Although the Act has provided good coverage for the use of ART over the last 16 years, it did not have a revision clause. Here, we explore whether the HART Act should be reviewed, and outline the important considerations that need to be taken into account to ensure that the legislation is up to date with current issues and technologies.

The Birth of Assisted Reproductive Technology in China

Good Quality ◽  
2018 ◽  
Author(s):  
Ayo Wahlberg
Keyword(s):  
Family Planning ◽  
Assisted Reproductive Technology ◽  
Birth Control ◽  
Assisted Reproductive Technologies ◽  
Reproductive Technologies ◽  
Reproductive Technology ◽  
The Core ◽  
Sperm Banks ◽  
Population Quality

This chapter chronicles the difficult birth of assisted reproductive technologies (ARTs) in China through the 1980s and 1990s, showing how ideas of improving population quality acted as a persuasive alibi for those pioneers working to develop fertility technologies under crude conditions and at a time when contraception rather than conception was at the core of family planning. From difficult beginnings in the 1980s and following legalization in 2003, ARTs have now settled firmly within China’s restrictive reproductive complex as technologies of birth control—which, in turn, has allowed it to grow into a thriving, sector as China is now home to some of the world’s largest fertility clinics and sperm banks.

Assisted Reproductive Technology in Spain: Considering Women's Interests

2009 ◽  
Vol 18 (3) ◽  
pp. 228-235 ◽  
Author(s):  
INMACULADA DE MELO-MARTÍN
Keyword(s):  
Assisted Reproductive Technology ◽  
Assisted Reproductive Technologies ◽  
Reproductive Technologies ◽  
Reproductive Technology ◽  
Assisted Conception ◽  
National Healthcare ◽  
The World ◽  
National Healthcare System ◽  
The Subject ◽  
Catholic Tradition

It might come as a surprise to many that Spain, a country with a strong Catholic tradition that officially banned contraceptive technologies until 1978, has some of the most liberal regulations in assisted reproduction in the world. Law No. 35/1988 was one of the first and most detailed acts of legislation undertaken on the subject of assisted-conception procedures. Indeed, not only did the law permit research on nonviable embryos, it made assisted reproductive technologies available to any woman, whether married or not, through the national healthcare system.

scholarly journals Genetic identity concerns in the regulation of novel reproductive technologies

2020 ◽  
Author(s):  
Karinne Ludlow
Keyword(s):  
Regulatory Reform ◽  
Reproductive Technologies ◽  
Reproductive Technology ◽  
Genetic Identity ◽  
Human Embryos ◽  
Regulatory Activity ◽  
Novel Technologies ◽  
History Of ◽  
Common Objection

Abstract Confusion concerning a child’s genetic identity is a common objection to the application of novel technologies to human embryos. Unsurprisingly then, concern for genetic identity has been used to justify successive waves of regulatory activity and is again appearing in debates about regulatory responses to emerging reproductive technologies. By examining the history of Australian law’s understanding and responses to so-called genetic identity in the context of past and current scientific developments in reproductive technology, this paper investigates regulatory reform needed for still emerging reproductive technologies. While this paper presents and analyzes in some detail Australian regulation and the policy deliberations and scientific developments that led to them, the identified inconsistencies in the regulatory responses, and recommended reforms to address emerging reproductive technologies offered, address issues relevant to many countries responding to the same technologies.

The Affordable Care Act and assisted reproductive technology use

2015 ◽  
Vol 34 (2) ◽  
pp. 71-90 ◽  
Author(s):  
Patricia Stapleton ◽  
Daniel Skinner
Keyword(s):  
Affordable Care Act ◽  
Technology Use ◽  
Assisted Reproductive Technologies ◽  
Insurance Coverage ◽  
The United States ◽  
Reproductive Technologies ◽  
Gender And Sexuality ◽  
Insurance Markets ◽  
The Affordable Care Act ◽  
American Society

The Affordable Care Act (ACA) has prompted numerous gender and sexuality controversies. We describe and analyze those involving assisted reproductive technologies (ART). ART in the United States has been regulated in piecemeal fashion, with oversight primarily by individual states. While leaving state authority largely intact, the ACA federalized key practices by establishing essential health benefits (EHBs) that regulate insurance markets and prohibit insurance-coverage denials based on pre-existing conditions. Whatever their intentions, the ACA’s drafters thus put infertility in a subtly provocative new light clinically, financially, normatively, politically, and culturally. With particular attention to normative and political dynamics embedded in plausible regulatory trajectories, we review—and attempt topreview—the ACA’s effects on infertility-related delivery of health services, on ART utilization, and on reproductive medicine as a factor in American society.

Sign in / Sign up

Export Citation Format

Share Document